CD8A and neoplasm: Tregs serve as key immunosuppressive cells in the setting of tumor immunity, while abundant cytotoxic CD8+ T cells are generally correlated with favorable prognosis and clinical response to immunotherapy (Sautes-Fridman et al. 2019; Nishikawa and Koyama 2021).